
Investors
GSK is a science-led global healthcare company that aims to deliver growth and improving returns to shareholders through the development of innovative pharmaceutical and vaccine products.
As a listed entity, we have a responsibility to communicate our strategy and performance to investors in order to promote confidence. Information for investors includes share information, share analysis, shareholder news and annual reports.

Stock Exchange Symbol
GLAXO
Compliance Certificate
GSK Pakistan's Compliance CertificatePDF - 266.1KBCorporate Briefing Session GSK Pakistan
Corporate Briefing Session Letter 2022PDF - 588.9KB Corporate Briefing Presentation 2022PDF - 2.0MB Corporate Briefing Session 2022 AudioMP3 - 12.5MBFor complaints or queries please contact:
Ms. Mehar-e-daraksha Ameer
Legal Director/Company Secretary
Email: PK.Shareinfo@gsk.com
Phone No: +9221 111 475 725
Erum Shakir Rahim CEO - GSK
Reflections on 2021 performance
Source- IQVIA: MAT Dec '21

DISCLAIMER: “In case your complaint has not been properly redressed by us, you may lodge your complaint with Securities and Exchange Commission of Pakistan (the “SECP”). However, please note that SECP will entertain only those complaints which were at first directly requested to be redressed by the Company and the company has failed to redress the same. Further, the complaints that are not relevant to SECP’s regulatory domain/competence shall not be entertained.”
Find out more
-
Research & development
Science can improve health and well-being in so many ways, from the development of everyday convenience healthcare products.
-
Products
We make a wide range of prescription medicines and vaccines
-
GSK in Pakistan
GSK is a long-established investor in Pakistan. Our legacy company GlaxoLaboratories Pakistan Ltd.
-
Careers
We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.